• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

435
72
49
48
25

COUNTRY

47
17
5
5
5

PRICE

20
298
578
1,522

PUBLISHED

5
53
439
1,522

PRODUCT TYPE

1,485
18
14
5

Central Nervous System

(1,522 Products)

In 2012 major changes might revolutionize the treatment of multiple sclerosis, as Gilenya, the first novel drug in five years, will be joined by three new products: BG-12, Aubagio, and Lemtrada. Recent exciting developments in drug discovery might also enhance the hopes of those fighting against Alzheimer.

Great commercial and scientific opportunities are to be found in similar battles against a range of diseases and neurodegenerative disorders, e.g. Parkinson’s disease, schizophrenia, migraine, insomnia, epilepsy, etc.

A wide selection of industry reports, scientific journals and academic textbooks in this section allow readers to explore every conceivable facet of this industry, such as market trends, industry forecasts, new drugs in development, the latest research & development, patent applications, and licensing strategies.

Key players featured in our publications include Biogen Idec, Sanofi, Genzyme, and many more. Show Less
Read more

PRODUCT TITLE
Germany Central Nervous System Drugs Market Insights - 2015 Germany Central Nervous System Drugs Market Insights - 2015 - Product Thumbnail Image

Germany Central Nervous System Drugs Market Insights - 2015

The latest research Germany Central Nervous System Drugs Market Insights – 2015, provides CNS drugs market analysis, key products, and competitive landscape in Germany. The research includes CNS drugs...

March 2015
FROM
South Korea Central Nervous System Drugs Market Insights - 2015 South Korea Central Nervous System Drugs Market Insights - 2015 - Product Thumbnail Image

South Korea Central Nervous System Drugs Market Insights - 2015

The latest research South Korea Central Nervous System Drugs Market Insights – 2015, provides CNS drugs market analysis, key products, and competitive landscape in South Korea. The research includes...

March 2015
FROM
Russia Central Nervous System Drugs Market Insights - 2015 Russia Central Nervous System Drugs Market Insights - 2015 - Product Thumbnail Image

Russia Central Nervous System Drugs Market Insights - 2015

The latest research Russia Central Nervous System Drugs Market Insights – 2015, provides CNS drugs market analysis, key products, and competitive landscape in Russia. The research includes CNS drugs...

March 2015
FROM
Canada Central Nervous System Drugs Market Insights - 2015 Canada Central Nervous System Drugs Market Insights - 2015 - Product Thumbnail Image

Canada Central Nervous System Drugs Market Insights - 2015

The latest research Canada Central Nervous System Drugs Market Insights – 2015, provides CNS drugs market analysis, key products, and competitive landscape in Canada. The research includes CNS drugs...

March 2015
FROM
Spain Central Nervous System Drugs Market Insights - 2015 Spain Central Nervous System Drugs Market Insights - 2015 - Product Thumbnail Image

Spain Central Nervous System Drugs Market Insights - 2015

The latest research Spain Central Nervous System Drugs Market Insights – 2015, provides CNS drugs market analysis, key products, and competitive landscape in Spain. The research includes CNS drugs...

March 2015
FROM

Dyskinesia - Pipeline Review, H1 2015

Dyskinesia - Pipeline Review, H1 2015 Summary This, ‘Dyskinesia - Pipeline Review, H1 2015’, provides an overview of the Dyskinesia’s therapeutic pipeline. This report provides comprehensive information...

March 2015
FROM
Epilepsy and Brain Tumors Epilepsy and Brain Tumors - Product Thumbnail Image

Epilepsy and Brain Tumors

Patients with brain tumor-related epilepsy (BTRE) suffer from two serious pathologies simultaneously - a brain tumor and a secondary form of epilepsy.  Although there has been remarkable progress in...

March 2015

Delirium Global Clinical Trials Review, H1, 2015

Delirium Global Clinical Trials Review, H1, 2015 Summary Our clinical trial report, “Delirium Global Clinical Trials Review, H1, 2015" provides data on the Delirium clinical trial scenario. This report...

February 2015
FROM

Dyslexia Global Clinical Trials Review, H1, 2015

Dyslexia Global Clinical Trials Review, H1, 2015 Summary Our clinical trial report, “Dyslexia Global Clinical Trials Review, H1, 2015" provides data on the Dyslexia clinical trial scenario. This report...

February 2015
FROM

Dyskinesia Global Clinical Trials Review, H1, 2015

Dyskinesia Global Clinical Trials Review, H1, 2015 Summary Our clinical trial report, “Dyskinesia Global Clinical Trials Review, H1, 2015" provides data on the Dyskinesia clinical trial scenario....

February 2015
FROM

Hyperalgesia Global Clinical Trials Review, H1, 2015

Hyperalgesia Global Clinical Trials Review, H1, 2015 Summary Our clinical trial report, “Hyperalgesia Global Clinical Trials Review, H1, 2015" provides data on the Hyperalgesia clinical trial scenario....

February 2015
FROM

Nicotine Addiction Global Clinical Trials Review, H1, 2015

Nicotine Addiction Global Clinical Trials Review, H1, 2015 Summary Our clinical trial report, “Nicotine Addiction Global Clinical Trials Review, H1, 2015" provides data on the Nicotine Addiction clinical...

February 2015
FROM

PharmaPoint: Insomnia - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: Insomnia - Global Drug Forecast and Market Analysis to 2023 Summary Insomnia is the most common sleep disorder and is believed to affect approximately 35% of the global population. The...

February 2015
FROM

PharmaPoint: Alzheimer's Disease - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: Alzheimer’s Disease - Global Drug Forecast and Market Analysis to 2023 Summary Alzheimer’s Disease (AD) is a progressive neurodegenerative disease that is characterized by memory loss,...

February 2015
FROM

Encephalomyelitis - Pipeline Review, H1 2015

Encephalomyelitis - Pipeline Review, H1 2015 Summary This, ‘Encephalomyelitis - Pipeline Review, H1 2015’, provides an overview of the Encephalomyelitis’s therapeutic pipeline. This report provides...

February 2015
FROM

Visceral Pain - Pipeline Review, H1 2015

Visceral Pain - Pipeline Review, H1 2015 Summary This ‘Visceral Pain - Pipeline Review, H1 2015’, provides an overview of the Visceral Pain’s therapeutic pipeline. This report provides comprehensive...

February 2015
FROM

Neuromyelitis Optica (Devic's Syndrome) - Pipeline Review, H1 2015

Neuromyelitis Optica (Devic’s Syndrome) - Pipeline Review, H1 2015 Summary This ‘Neuromyelitis Optica (Devic’s Syndrome) - Pipeline Review, H1 2015’, provides an overview of the Neuromyelitis...

February 2015
FROM

Anorexia Nervosa Global Clinical Trials Review, H1, 2015

Anorexia Nervosa Global Clinical Trials Review, H1, 2015 Summary This new clinical trial report, “Anorexia Nervosa Global Clinical Trials Review, H1, 2015" provides data on the Anorexia Nervosa...

February 2015
FROM

Friedreich Ataxia Global Clinical Trials Review, H1, 2015

Friedreich Ataxia Global Clinical Trials Review, H1, 2015 Summary This new clinical trial report, “Friedreich Ataxia Global Clinical Trials Review, H1, 2015" provides data on the Friedreich Ataxia...

February 2015
FROM

Lennox-Gastaut Syndrome Global Clinical Trials Review, H1, 2015

Lennox-Gastaut Syndrome Global Clinical Trials Review, H1, 2015 Summary This new clinical trial report, “Lennox-Gastaut Syndrome Global Clinical Trials Review, H1, 2015" provides data on the Lennox-Gastaut...

February 2015
FROM
Loading Indicator

Our Clients

Shire PLC. GlaxoSmithKline PLC Astrazeneca PLC Roche Diagnostics Ltd. H. Lundbeck A/S Electrical Geodesics, Inc.